Seattle Genetics reported $-190816000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
Acadia Pharmaceuticals ACAD:US USD -27183000 6.83M
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Amgen AMGN:US USD 1.62B 527M
Bayer BAYN:GR EUR 546M 844M
Biogen BIIB:US USD 1.13B 76.7M
Biomarin Pharmaceutical BMRN:US USD -6652000 34.32M
Bluebird Bio BLUE:US USD -76520000 23.62M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Clovis Oncology CLVS:US USD -56014000 15.32M
Daiichi Sankyo 4568:JP JPY 28.39B 11.07B
Eli Lilly And LLY:US USD 1.94B 486M
Esperion Therapeutics ESPR:US USD -55117000 11.21M
Genmab GEN:DC DKK 2.58B 691M
Gilead Sciences GILD:US USD 1.64B 149M
GlaxoSmithKline GSK:LN GBP 1.5B 8.82B
Glaxosmithkline GSK:US GBP 1.5B 8.82B
Immunogen IMGN:US USD -77755000 15.73M
Insmed INSM:US USD -131145000 35.5M
Karyopharm Therapeutics KPTI:US USD -36324000 12.74M
Macrogenics MGNX:US USD -24813000 16.49M
Merk MRK:US USD 3.02B 231M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Moderna Inc MRNA:US USD 1.04B 1.15B
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Novartis NOVN:VX USD 1.47B 107M
Pfizer PFE:US USD 5B 3.61B
Regeneron Pharmaceuticals REGN:US USD 1.2B 118.6M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Seattle Genetics SGEN:US USD -190816000 55.99M
Takeda 4502:JP JPY 119.13B 57.39B
Xencor XNCR:US USD -32759000 1.22M